Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: For whom and when should interventions be tested?

M. A. Pulsipher, B. Langholz, D. A. Wall, K. R. Schultz, N. Bunin, W. Carroll, E. Raetz, S. Gardner, R. K. Goyal, J. Gastier-Foster, Michael J Borowitz, D. Teachey, S. A. Grupp

Research output: Contribution to journalArticle

Abstract

We previously showed that minimal residual disease (MRD) detection pre-hematopoietic cell transplant (HCT) and acute GvHD (aGvHD) independently predicted risk of relapse in pediatric ALL. In this study we further define risk by assessing timing of relapse and the effects of leukemia risk category and post-HCT MRD. By multivariate analysis, pre-HCT MRD

Original languageEnglish (US)
Pages (from-to)1173-1179
Number of pages7
JournalBone Marrow Transplantation
Volume50
Issue number9
DOIs
StatePublished - Sep 4 2015

Fingerprint

Homologous Transplantation
Residual Neoplasm
Pediatrics
Transplants
Recurrence
Leukemia
Multivariate Analysis

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL : For whom and when should interventions be tested? / Pulsipher, M. A.; Langholz, B.; Wall, D. A.; Schultz, K. R.; Bunin, N.; Carroll, W.; Raetz, E.; Gardner, S.; Goyal, R. K.; Gastier-Foster, J.; Borowitz, Michael J; Teachey, D.; Grupp, S. A.

In: Bone Marrow Transplantation, Vol. 50, No. 9, 04.09.2015, p. 1173-1179.

Research output: Contribution to journalArticle

Pulsipher, MA, Langholz, B, Wall, DA, Schultz, KR, Bunin, N, Carroll, W, Raetz, E, Gardner, S, Goyal, RK, Gastier-Foster, J, Borowitz, MJ, Teachey, D & Grupp, SA 2015, 'Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: For whom and when should interventions be tested?', Bone Marrow Transplantation, vol. 50, no. 9, pp. 1173-1179. https://doi.org/10.1038/bmt.2015.103
Pulsipher, M. A. ; Langholz, B. ; Wall, D. A. ; Schultz, K. R. ; Bunin, N. ; Carroll, W. ; Raetz, E. ; Gardner, S. ; Goyal, R. K. ; Gastier-Foster, J. ; Borowitz, Michael J ; Teachey, D. ; Grupp, S. A. / Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL : For whom and when should interventions be tested?. In: Bone Marrow Transplantation. 2015 ; Vol. 50, No. 9. pp. 1173-1179.
@article{4d7a238542b544e184361add987a8a90,
title = "Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: For whom and when should interventions be tested?",
abstract = "We previously showed that minimal residual disease (MRD) detection pre-hematopoietic cell transplant (HCT) and acute GvHD (aGvHD) independently predicted risk of relapse in pediatric ALL. In this study we further define risk by assessing timing of relapse and the effects of leukemia risk category and post-HCT MRD. By multivariate analysis, pre-HCT MRD",
author = "Pulsipher, {M. A.} and B. Langholz and Wall, {D. A.} and Schultz, {K. R.} and N. Bunin and W. Carroll and E. Raetz and S. Gardner and Goyal, {R. K.} and J. Gastier-Foster and Borowitz, {Michael J} and D. Teachey and Grupp, {S. A.}",
year = "2015",
month = "9",
day = "4",
doi = "10.1038/bmt.2015.103",
language = "English (US)",
volume = "50",
pages = "1173--1179",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL

T2 - For whom and when should interventions be tested?

AU - Pulsipher, M. A.

AU - Langholz, B.

AU - Wall, D. A.

AU - Schultz, K. R.

AU - Bunin, N.

AU - Carroll, W.

AU - Raetz, E.

AU - Gardner, S.

AU - Goyal, R. K.

AU - Gastier-Foster, J.

AU - Borowitz, Michael J

AU - Teachey, D.

AU - Grupp, S. A.

PY - 2015/9/4

Y1 - 2015/9/4

N2 - We previously showed that minimal residual disease (MRD) detection pre-hematopoietic cell transplant (HCT) and acute GvHD (aGvHD) independently predicted risk of relapse in pediatric ALL. In this study we further define risk by assessing timing of relapse and the effects of leukemia risk category and post-HCT MRD. By multivariate analysis, pre-HCT MRD

AB - We previously showed that minimal residual disease (MRD) detection pre-hematopoietic cell transplant (HCT) and acute GvHD (aGvHD) independently predicted risk of relapse in pediatric ALL. In this study we further define risk by assessing timing of relapse and the effects of leukemia risk category and post-HCT MRD. By multivariate analysis, pre-HCT MRD

UR - http://www.scopus.com/inward/record.url?scp=84940900368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940900368&partnerID=8YFLogxK

U2 - 10.1038/bmt.2015.103

DO - 10.1038/bmt.2015.103

M3 - Article

C2 - 25961775

AN - SCOPUS:84940900368

VL - 50

SP - 1173

EP - 1179

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 9

ER -